Mankind Pharma Limited (NSE:MANKIND)
India
· Delayed Price · Currency is INR 2,333.40
+29.90 (1.30%)
Jun 27, 2025, 3:30 PM IST
Mankind Pharma Market Cap
Mankind Pharma has a market cap or net worth of 973.34 billion as of June 27, 2025. Its market cap has increased by 16.02% in one year.
Market Cap
973.34B
Enterprise Value
1.04T
Revenue
122.07B
Ranking
n/a
PE Ratio
48.04
Stock Price
2,333.40
Market Cap Chart
Since May 9, 2023, Mankind Pharma's market cap has increased from 569.76B to 973.34B, an increase of 70.83%. That is a compound annual growth rate of 28.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2025 | 973.34B | -18.09% |
| Dec 31, 2024 | 1,188.36B | 49.64% |
| Dec 29, 2023 | 794.17B | 39.39% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 3,954.10B |
| Divi's Laboratories | 1,738.55B |
| Cipla | 1,210.03B |
| Apollo Hospitals Enterprise | 1,050.85B |
| Zydus Lifesciences | 964.27B |
| Aurobindo Pharma | 641.96B |
| Fortis Healthcare | 591.89B |
| Alkem Laboratories | 586.65B |